Topic: U.S. Reproductive Health Initiative
The U.S. Supreme Court unanimously rejected a challenge to the Food and Drug Administration (FDA)’s authority to regulate mifepristone, a medication used in early abortion. The ruling is critical for providing continued access to mifepristone at a time when more people than ever face barriers to making their own choices about their health care since … Continued